<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For more than a half century, <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> has been linked to a diverse array of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart diseases</z:e>, including rheumatic <z:mp ids='MP_0001853'>carditis</z:mp>, <z:mp ids='MP_0001856'>myocarditis</z:mp>, Chagas' <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, post-<z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="C0152107" disease_type="Disease or Syndrome" abbrv="">Dressler</z:e>'s) syndrome, and idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Why the heart is targeted by <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> in these seemingly unrelated conditions has remained enigmatic </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we discuss our recent studies indicating that this susceptibility is mediated by impaired negative selection of autoreactive Î±-myosin heavy-chain-specific CD4(+) T cells in the thymus of both mice and humans </plain></SENT>
<SENT sid="3" pm="."><plain>We describe how this process may place the heart at increased risk for autoimmune attack following ischemic or infectious injury, providing a rationale for the development of antigen-specific tolerogenic therapies </plain></SENT>
</text></document>